The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Calcium Channel Blocker Market Research Report 2025
Synopsis
Calcium channel blockers（CCBs） are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.
The global Calcium Channel Blocker market was valued at US$ 77 million in 2023 and is anticipated to reach US$ 86 million by 2030, witnessing a CAGR of 1.6% during the forecast period 2024-2030.
Global Calcium Channel Blocker key players include Pfizer, Aventis, Searle, Bayer, AstraZeneca, etc.
North America is the largest market, with a share about 30%, followed by Europe, and China, both have a share about 40 percent.
In terms of product, Amlodipine is the largest segment, with a share over 55%. And in terms of application, the largest application is Hypertension, followed by CHD, etc.
This report aims to provide a comprehensive presentation of the global market for Calcium Channel Blocker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Calcium Channel Blocker.
Report Scope
The Calcium Channel Blocker market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Calcium Channel Blocker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Calcium Channel Blocker manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Aventis
Searle
Bayer
AstraZeneca
Knoll Pharmaceuticals
Wyeth-Ayerst
AstraZeneca
Novartis
Sanofi
Segment by Type
Dihydropyridine
Diltiazem
Verapamil
Others
Segment by Application
Hypertension
Coronary Artery Disease
Arrhythmia
Cardiomyopathy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Calcium Channel Blocker manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Calcium Channel Blocker in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Calcium channel blockers（CCBs） are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.
The global Calcium Channel Blocker market was valued at US$ 77 million in 2023 and is anticipated to reach US$ 86 million by 2030, witnessing a CAGR of 1.6% during the forecast period 2024-2030.
Global Calcium Channel Blocker key players include Pfizer, Aventis, Searle, Bayer, AstraZeneca, etc.
North America is the largest market, with a share about 30%, followed by Europe, and China, both have a share about 40 percent.
In terms of product, Amlodipine is the largest segment, with a share over 55%. And in terms of application, the largest application is Hypertension, followed by CHD, etc.
This report aims to provide a comprehensive presentation of the global market for Calcium Channel Blocker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Calcium Channel Blocker.
Report Scope
The Calcium Channel Blocker market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Calcium Channel Blocker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Calcium Channel Blocker manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Aventis
Searle
Bayer
AstraZeneca
Knoll Pharmaceuticals
Wyeth-Ayerst
AstraZeneca
Novartis
Sanofi
Segment by Type
Dihydropyridine
Diltiazem
Verapamil
Others
Segment by Application
Hypertension
Coronary Artery Disease
Arrhythmia
Cardiomyopathy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Calcium Channel Blocker manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Calcium Channel Blocker in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Calcium Channel Blocker Market Overview
1.1 Product Overview and Scope of Calcium Channel Blocker
1.2 Calcium Channel Blocker Segment by Type
1.2.1 Global Calcium Channel Blocker Market Value Comparison by Type (2024-2030)
1.2.2 Dihydropyridine
1.2.3 Diltiazem
1.2.4 Verapamil
1.2.5 Others
1.3 Calcium Channel Blocker Segment by Application
1.3.1 Global Calcium Channel Blocker Market Value by Application: (2024-2030)
1.3.2 Hypertension
1.3.3 Coronary Artery Disease
1.3.4 Arrhythmia
1.3.5 Cardiomyopathy
1.4 Global Calcium Channel Blocker Market Size Estimates and Forecasts
1.4.1 Global Calcium Channel Blocker Revenue 2019-2030
1.4.2 Global Calcium Channel Blocker Sales 2019-2030
1.4.3 Global Calcium Channel Blocker Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Calcium Channel Blocker Market Competition by Manufacturers
2.1 Global Calcium Channel Blocker Sales Market Share by Manufacturers (2019-2024)
2.2 Global Calcium Channel Blocker Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Calcium Channel Blocker Average Price by Manufacturers (2019-2024)
2.4 Global Calcium Channel Blocker Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Calcium Channel Blocker, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Calcium Channel Blocker, Product Type & Application
2.7 Calcium Channel Blocker Market Competitive Situation and Trends
2.7.1 Calcium Channel Blocker Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Calcium Channel Blocker Players Market Share by Revenue
2.7.3 Global Calcium Channel Blocker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Calcium Channel Blocker Retrospective Market Scenario by Region
3.1 Global Calcium Channel Blocker Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Calcium Channel Blocker Global Calcium Channel Blocker Sales by Region: 2019-2030
3.2.1 Global Calcium Channel Blocker Sales by Region: 2019-2024
3.2.2 Global Calcium Channel Blocker Sales by Region: 2025-2030
3.3 Global Calcium Channel Blocker Global Calcium Channel Blocker Revenue by Region: 2019-2030
3.3.1 Global Calcium Channel Blocker Revenue by Region: 2019-2024
3.3.2 Global Calcium Channel Blocker Revenue by Region: 2025-2030
3.4 North America Calcium Channel Blocker Market Facts & Figures by Country
3.4.1 North America Calcium Channel Blocker Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Calcium Channel Blocker Sales by Country (2019-2030)
3.4.3 North America Calcium Channel Blocker Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Calcium Channel Blocker Market Facts & Figures by Country
3.5.1 Europe Calcium Channel Blocker Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Calcium Channel Blocker Sales by Country (2019-2030)
3.5.3 Europe Calcium Channel Blocker Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Calcium Channel Blocker Market Facts & Figures by Country
3.6.1 Asia Pacific Calcium Channel Blocker Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Calcium Channel Blocker Sales by Country (2019-2030)
3.6.3 Asia Pacific Calcium Channel Blocker Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Calcium Channel Blocker Market Facts & Figures by Country
3.7.1 Latin America Calcium Channel Blocker Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Calcium Channel Blocker Sales by Country (2019-2030)
3.7.3 Latin America Calcium Channel Blocker Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Calcium Channel Blocker Market Facts & Figures by Country
3.8.1 Middle East and Africa Calcium Channel Blocker Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Calcium Channel Blocker Sales by Country (2019-2030)
3.8.3 Middle East and Africa Calcium Channel Blocker Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Calcium Channel Blocker Sales by Type (2019-2030)
4.1.1 Global Calcium Channel Blocker Sales by Type (2019-2024)
4.1.2 Global Calcium Channel Blocker Sales by Type (2025-2030)
4.1.3 Global Calcium Channel Blocker Sales Market Share by Type (2019-2030)
4.2 Global Calcium Channel Blocker Revenue by Type (2019-2030)
4.2.1 Global Calcium Channel Blocker Revenue by Type (2019-2024)
4.2.2 Global Calcium Channel Blocker Revenue by Type (2025-2030)
4.2.3 Global Calcium Channel Blocker Revenue Market Share by Type (2019-2030)
4.3 Global Calcium Channel Blocker Price by Type (2019-2030)
5 Segment by Application
5.1 Global Calcium Channel Blocker Sales by Application (2019-2030)
5.1.1 Global Calcium Channel Blocker Sales by Application (2019-2024)
5.1.2 Global Calcium Channel Blocker Sales by Application (2025-2030)
5.1.3 Global Calcium Channel Blocker Sales Market Share by Application (2019-2030)
5.2 Global Calcium Channel Blocker Revenue by Application (2019-2030)
5.2.1 Global Calcium Channel Blocker Revenue by Application (2019-2024)
5.2.2 Global Calcium Channel Blocker Revenue by Application (2025-2030)
5.2.3 Global Calcium Channel Blocker Revenue Market Share by Application (2019-2030)
5.3 Global Calcium Channel Blocker Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Calcium Channel Blocker Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Calcium Channel Blocker Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Aventis
6.2.1 Aventis Corporation Information
6.2.2 Aventis Description and Business Overview
6.2.3 Aventis Calcium Channel Blocker Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Aventis Calcium Channel Blocker Product Portfolio
6.2.5 Aventis Recent Developments/Updates
6.3 Searle
6.3.1 Searle Corporation Information
6.3.2 Searle Description and Business Overview
6.3.3 Searle Calcium Channel Blocker Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Searle Calcium Channel Blocker Product Portfolio
6.3.5 Searle Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Calcium Channel Blocker Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bayer Calcium Channel Blocker Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Calcium Channel Blocker Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AstraZeneca Calcium Channel Blocker Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Knoll Pharmaceuticals
6.6.1 Knoll Pharmaceuticals Corporation Information
6.6.2 Knoll Pharmaceuticals Description and Business Overview
6.6.3 Knoll Pharmaceuticals Calcium Channel Blocker Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Knoll Pharmaceuticals Calcium Channel Blocker Product Portfolio
6.6.5 Knoll Pharmaceuticals Recent Developments/Updates
6.7 Wyeth-Ayerst
6.6.1 Wyeth-Ayerst Corporation Information
6.6.2 Wyeth-Ayerst Description and Business Overview
6.6.3 Wyeth-Ayerst Calcium Channel Blocker Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Wyeth-Ayerst Calcium Channel Blocker Product Portfolio
6.7.5 Wyeth-Ayerst Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Calcium Channel Blocker Sales, Revenue and Gross Margin (2019-2024)
6.8.4 AstraZeneca Calcium Channel Blocker Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Novartis
6.9.1 Novartis Corporation Information
6.9.2 Novartis Description and Business Overview
6.9.3 Novartis Calcium Channel Blocker Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Novartis Calcium Channel Blocker Product Portfolio
6.9.5 Novartis Recent Developments/Updates
6.10 Sanofi
6.10.1 Sanofi Corporation Information
6.10.2 Sanofi Description and Business Overview
6.10.3 Sanofi Calcium Channel Blocker Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sanofi Calcium Channel Blocker Product Portfolio
6.10.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Calcium Channel Blocker Industry Chain Analysis
7.2 Calcium Channel Blocker Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Calcium Channel Blocker Production Mode & Process
7.4 Calcium Channel Blocker Sales and Marketing
7.4.1 Calcium Channel Blocker Sales Channels
7.4.2 Calcium Channel Blocker Distributors
7.5 Calcium Channel Blocker Customers
8 Calcium Channel Blocker Market Dynamics
8.1 Calcium Channel Blocker Industry Trends
8.2 Calcium Channel Blocker Market Drivers
8.3 Calcium Channel Blocker Market Challenges
8.4 Calcium Channel Blocker Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
